Free Trial

Tenaya Therapeutics (TNYA) Short Interest Ratio & Short Volume

Tenaya Therapeutics logo
$0.70 +0.01 (+2.17%)
As of 11:10 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Tenaya Therapeutics Short Interest Data

Tenaya Therapeutics (TNYA) has a short interest of 10.70 million shares, representing 7.97% of the float (the number of shares available for trading by the public). This marks a -10.01% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.5, indicating that it would take 4.5 days of the average trading volume of 2.74 million shares to cover all short positions.

Current Short Interest
10,700,000 shares
Previous Short Interest
11,890,000 shares
Change Vs. Previous Month
-10.01%
Dollar Volume Sold Short
$6.54 million
Short Interest Ratio
4.5 Days to Cover
Last Record Date
June 30, 2025
Outstanding Shares
162,667,000 shares
Float Size
134,180,000 shares
Short Percent of Float
7.97%
Today's Trading Volume
599,325 shares
Average Trading Volume
2,736,925 shares
Today's Volume Vs. Average
22%
Short Selling Tenaya Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Tenaya Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TNYA Short Interest Over Time

TNYA Days to Cover Over Time

TNYA Percentage of Float Shorted Over Time

Tenaya Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/202510,700,000 shares $6.54 million -10.0%8.0%4.5 $0.61
6/15/202511,890,000 shares $7.03 million -1.3%8.9%4.9 $0.59
5/31/202512,050,000 shares $5.45 million -0.9%9.0%3.9 $0.45
5/15/202512,160,000 shares $5.32 million +39.3%9.1%3.5 $0.44
4/30/20258,730,000 shares $4.15 million -0.5%6.5%2.6 $0.48
4/15/20258,770,000 shares $4.45 million -19.0%6.5%2.7 $0.51
3/31/202510,820,000 shares $6.17 million -3.6%8.1%3.2 $0.57
3/15/202511,220,000 shares $7.84 million -22.1%8.4%3 $0.70
2/28/202514,400,000 shares $14.54 million +7.7%11.3%3.4 $1.01
2/15/202513,370,000 shares $16.04 million +9.2%20.5%3.4 $1.20
1/31/202512,240,000 shares $12.97 million +6.6%18.7%2.8 $1.06
1/15/202511,480,000 shares $16.88 million -7.6%17.5%2.4 $1.47
12/31/202412,420,000 shares $17.76 million -25.6%18.9%2.6 $1.43
12/15/202416,690,000 shares $45.90 million +18.8%25.4%3.8 $2.75
11/30/202414,050,000 shares $50.16 million +7.1%21.4%4.8 $3.57
11/15/202413,120,000 shares $25.85 million +150.4%20.0%5.7 $1.97
10/31/20245,240,000 shares $10.06 million +7.4%8.0%3.4 $1.92
10/15/20244,880,000 shares $8.25 million -3.9%7.5%10.6 $1.69
9/30/20245,080,000 shares $9.80 million -2.7%7.8%12.9 $1.93
9/15/20245,220,000 shares $10.44 million +11.1%8.0%12.6 $2.00
8/31/20244,700,000 shares $12.60 million +1.5%7.2%12.4 $2.68
8/15/20244,630,000 shares $13.89 million +4.5%7.1%12.4 $3.00
7/31/20244,430,000 shares $15.51 million +0.9%6.8%12 $3.50
7/15/20244,390,000 shares $15.45 million +12.9%6.7%12.4 $3.52
6/30/20243,890,000 shares $12.06 million +15.1%6.0%11 $3.10
6/15/20243,380,000 shares $11.36 million -1.7%5.2%11.1 $3.36
5/31/20243,440,000 shares $14.48 million +2.7%5.3%9.1 $4.21
5/15/20243,350,000 shares $14.24 million -7.7%5.1%7.8 $4.25
4/30/20243,630,000 shares $16.48 million +7.7%5.8%7.2 $4.54
4/15/20243,370,000 shares $15.06 million +9.1%5.4%6.2 $4.47
3/31/20243,090,000 shares $16.16 million +21.2%5.0%5.1 $5.23
3/15/20242,550,000 shares $12.69 million -10.2%4.1%4.1 $4.98
2/29/20242,840,000 shares $16.90 million +14.5%4.7%5 $5.95
2/15/20242,480,000 shares $14.33 million -7.5%4.1%4.7 $5.78
1/31/20242,680,000 shares $11.27 million +14.0%6.0%5.9 $4.21
1/15/20242,350,000 shares $7.19 million -0.8%5.2%5.6 $3.06
12/31/20232,370,000 shares $7.68 million +19.7%5.3%6.8 $3.24
12/15/20231,980,000 shares $4.12 million -23.6%4.4%5.4 $2.08
11/30/20232,590,000 shares $4.87 million +5.3%5.8%6.9 $1.88
11/15/20232,460,000 shares $4.48 million -16.6%5.5%7.2 $1.82
The DOJ Just Paved the Way for Account Seizures (Ad)

Washington is running out of money…And guess where they'll look next? When governments go broke, they take from the people. It's happened before, and it's happening again. The Department of Justice just admitted that cash isn't legally YOUR property.

Get your free guide now by clicking here >>
10/31/20232,950,000 shares $5.37 million -2.0%6.6%8.6 $1.82
10/15/20233,010,000 shares $6.89 million -8.8%6.7%8.6 $2.29
9/30/20233,300,000 shares $8.42 million +3.1%7.4%9.4 $2.55
9/15/20233,200,000 shares $10.27 million +9.6%7.1%9.7 $3.21
8/31/20232,920,000 shares $11.30 million +3.6%6.6%9 $3.87
8/15/20232,820,000 shares $11.03 million +11.9%6.3%7.3 $3.91
7/31/20232,520,000 shares $12.20 million -23.9%6.2%5.2 $4.84
7/15/20233,310,000 shares $18.17 million +5.4%8.1%5 $5.49
6/30/20233,140,000 shares $18.43 million +6.4%7.7%4.6 $5.87
6/15/20232,950,000 shares $19.77 million +20.4%7.2%4.5 $6.70
5/31/20232,450,000 shares $17.64 million +18.9%6.0%3.7 $7.20
5/15/20232,060,000 shares $14.42 million +30.4%5.0%3.2 $7.00
4/30/20231,580,000 shares $8.40 million -6.5%3.9%2.6 $5.32
4/15/20231,690,000 shares $4.85 million +1.8%4.1%3.6 $2.87
3/31/20231,660,000 shares $4.73 million +84.6%4.2%4.7 $2.85
3/15/2023899,400 shares $2.36 million +14.9%2.3%2.5 $2.63
2/28/2023782,600 shares $2.40 million -10.3%2.1%2.7 $3.07
2/15/2023872,200 shares $2.67 million +3.9%2.3%2.7 $3.06
1/31/2023839,400 shares $2.87 million -2.4%2.1%2.3 $3.42
1/15/2023859,600 shares $1.97 million +2.4%2.2%2.8 $2.29
12/30/2022839,300 shares $1.69 million -15.2%2.1%3.1 $2.01
12/15/2022990,000 shares $2.35 million -14.7%2.0%3.6 $2.37
11/30/20221,160,000 shares $3.07 million -10.1%2.7%4.4 $2.65
11/15/20221,290,000 shares $3.78 million -0.8%3.1%5.6 $2.93
10/31/20221,300,000 shares $3.48 million -13.3%4.6%8.2 $2.68
10/15/20221,500,000 shares $3.69 million -1.3%5.3%9.3 $2.46
9/30/20221,520,000 shares $4.41 million No Change5.4%8.8 $2.90
9/15/20221,520,000 shares $6.10 million -6.2%5.4%8.4 $4.01
8/31/20221,620,000 shares $7.11 million -10.0%5.7%9.6 $4.39
8/15/20221,800,000 shares $10.31 million -26.8%6.4%10.9 $5.73
7/31/20222,460,000 shares $11.73 million No Change8.7%16.8 $4.77
7/15/20222,460,000 shares $12.79 million -39.0%8.7%19 $5.20
6/30/20224,030,000 shares $22.69 million +7.2%14.3%34.8 $5.63
6/15/20223,760,000 shares $20.45 million +1.6%13.3%34.6 $5.44
5/31/20223,700,000 shares $24.79 million -1.1%13.1%27.8 $6.70
5/15/20223,740,000 shares $26.55 million -0.5%13.3%25.4 $7.10
4/30/20223,760,000 shares $34.67 million +1.1%13.3%24.4 $9.22
4/15/20223,720,000 shares $42.56 million +1.6%13.2%22.7 $11.44
3/31/20223,660,000 shares $43.11 million +13.3%13.0%19.9 $11.78
3/15/20223,230,000 shares $37.08 million +10.6%11.4%17 $11.48
2/28/20222,920,000 shares $34.05 million +4.3%10.3%18.2 $11.66
2/15/20222,800,000 shares $42.53 million +4.9%9.9%18.4 $15.19
1/31/20222,670,000 shares $31.83 million +6.8%10.2%18.4 $11.92
1/15/20222,500,000 shares $25 million +25.6%9.5%19.2 $10.00
12/31/20211,990,000 shares $37.71 million No Change7.6%16.8 $18.95

TNYA Short Interest - Frequently Asked Questions

What is Tenaya Therapeutics' current short interest?

Short interest is the volume of Tenaya Therapeutics shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 10,700,000 shares of TNYA short. 7.97% of Tenaya Therapeutics' shares are currently sold short. Learn More on Tenaya Therapeutics' current short interest.

What is a good short interest ratio for Tenaya Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TNYA shares currently have a short interest ratio of 4.0. Learn More on Tenaya Therapeutics's short interest ratio.

Which institutional investors are shorting Tenaya Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Tenaya Therapeutics: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Tenaya Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.97% of Tenaya Therapeutics' floating shares are currently sold short.

Is Tenaya Therapeutics' short interest increasing or decreasing?

Tenaya Therapeutics saw a decline in short interest in June. As of June 30th, there was short interest totaling 10,700,000 shares, a decline of 10.0% from the previous total of 11,890,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Tenaya Therapeutics' float size?

Tenaya Therapeutics currently has issued a total of 162,667,000 shares. Some of Tenaya Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Tenaya Therapeutics currently has a public float of 134,180,000 shares.

How does Tenaya Therapeutics' short interest compare to its competitors?

7.97% of Tenaya Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Tenaya Therapeutics: Fulcrum Therapeutics, Inc. (11.24%), Checkpoint Therapeutics, Inc. (6.19%), Aquestive Therapeutics, Inc. (12.28%), CryoPort, Inc. (5.75%), Compass Therapeutics, Inc. (8.40%), Arcturus Therapeutics Holdings Inc. (20.30%), Altimmune, Inc. (40.09%), Benitec Biopharma Limited (4.44%), Astria Therapeutics, Inc. (7.00%), Terns Pharmaceuticals, Inc. (9.22%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks.

What does it mean to sell short Tenaya Therapeutics stock?

Short selling TNYA is an investing strategy that aims to generate trading profit from Tenaya Therapeutics as its price is falling. TNYA shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Tenaya Therapeutics?

A short squeeze for Tenaya Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TNYA, which in turn drives the price of the stock up even further.

How often is Tenaya Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TNYA, twice per month. The most recent reporting period available is June, 30 2025.




This page (NASDAQ:TNYA) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners